INVO Bioscience, Inc. (INVO)
USD 0.83
(-2.0%)
USD 0.83
(-2.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -6.88 Million USD | 38.79% |
| 2022 | -10.52 Million USD | -101.45% |
| 2021 | -5.21 Million USD | 2.48% |
| 2020 | -5.47 Million USD | -208.19% |
| 2019 | -1.76 Million USD | 31.98% |
| 2018 | -2.62 Million USD | -312.3% |
| 2017 | -678.48 Thousand USD | 69.76% |
| 2016 | -2.1 Million USD | -257.72% |
| 2015 | -4.92 Million USD | 64.71% |
| 2014 | -1.67 Million USD | -181.28% |
| 2013 | -697.27 Thousand USD | -9.79% |
| 2012 | -562.03 Thousand USD | 20.68% |
| 2011 | -681.77 Thousand USD | 54.59% |
| 2010 | 323.61 Thousand USD | 17.9% |
| 2009 | -1.32 Million USD | 1.36% |
| 2008 | -1.85 Million USD | -7375.61% |
| 2007 | -204.36 Thousand USD | -1448.06% |
| 2006 | -1602.00 USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -719.41 Thousand USD | 28.01% |
| 2024 Q2 | -1.67 Million USD | -38.67% |
| 2023 Q4 | -1.39 Million USD | -59.62% |
| 2023 Q1 | -2.25 Million USD | 14.2% |
| 2023 Q2 | -2.06 Million USD | 8.64% |
| 2023 FY | - USD | 38.79% |
| 2023 Q3 | -873.94 Thousand USD | 57.62% |
| 2022 Q3 | -2.46 Million USD | 11.79% |
| 2022 FY | - USD | -101.45% |
| 2022 Q4 | -2.63 Million USD | -6.52% |
| 2022 Q1 | -2.69 Million USD | -831.7% |
| 2022 Q2 | -2.79 Million USD | -3.72% |
| 2021 Q2 | -1.69 Million USD | -9.31% |
| 2021 Q3 | -2.34 Million USD | -38.23% |
| 2021 FY | - USD | 2.48% |
| 2021 Q4 | 368.92 Thousand USD | 115.76% |
| 2021 Q1 | -1.54 Million USD | 12.72% |
| 2020 FY | - USD | -208.19% |
| 2020 Q3 | -1.25 Million USD | -19.4% |
| 2020 Q4 | -1.77 Million USD | -40.99% |
| 2020 Q2 | -1.05 Million USD | 24.04% |
| 2020 Q1 | -1.38 Million USD | -89.7% |
| 2019 FY | - USD | 31.98% |
| 2019 Q2 | -60.68 Thousand USD | 82.52% |
| 2019 Q1 | -347.14 Thousand USD | 32.19% |
| 2019 Q3 | -623.24 Thousand USD | -926.97% |
| 2019 Q4 | -731.66 Thousand USD | -17.4% |
| 2018 Q3 | -188.48 Thousand USD | 89.47% |
| 2018 FY | - USD | -312.3% |
| 2018 Q1 | -139.14 Thousand USD | 28.87% |
| 2018 Q4 | -511.92 Thousand USD | -171.6% |
| 2018 Q2 | -1.78 Million USD | -1185.9% |
| 2017 Q4 | -195.62 Thousand USD | -36.93% |
| 2017 FY | - USD | 69.76% |
| 2017 Q3 | -142.87 Thousand USD | -7.9% |
| 2017 Q2 | -132.41 Thousand USD | 20.57% |
| 2017 Q1 | -166.7 Thousand USD | 38.33% |
| 2016 FY | - USD | -257.72% |
| 2016 Q4 | -270.29 Thousand USD | -30.34% |
| 2016 Q3 | -207.37 Thousand USD | 85.71% |
| 2016 Q2 | -1.45 Million USD | -709.8% |
| 2016 Q1 | -179.25 Thousand USD | 23.92% |
| 2015 Q4 | -235.61 Thousand USD | -100.77% |
| 2015 Q3 | -117.35 Thousand USD | -10.68% |
| 2015 Q1 | -130.43 Thousand USD | 0.0% |
| 2015 Q2 | -106.03 Thousand USD | 18.71% |
| 2015 FY | - USD | 64.71% |
| 2014 FY | - USD | -181.28% |
| 2013 FY | - USD | -9.79% |
| 2012 FY | - USD | 20.68% |
| 2011 Q1 | -170.61 Thousand USD | 58.26% |
| 2011 Q2 | -193.13 Thousand USD | -13.2% |
| 2011 Q3 | -168.97 Thousand USD | 12.51% |
| 2011 Q4 | -149.5 Thousand USD | 11.53% |
| 2011 FY | - USD | 54.59% |
| 2010 FY | - USD | 17.9% |
| 2010 Q1 | -424.61 Thousand USD | 8.77% |
| 2010 Q4 | -408.74 Thousand USD | -13.08% |
| 2010 Q2 | -306.5 Thousand USD | 27.82% |
| 2010 Q3 | -361.46 Thousand USD | -17.93% |
| 2009 Q3 | -290.9 Thousand USD | 33.16% |
| 2009 Q1 | -642.19 Thousand USD | 64.73% |
| 2009 FY | - USD | 1.36% |
| 2009 Q4 | -465.45 Thousand USD | -60.0% |
| 2009 Q2 | -435.22 Thousand USD | 32.23% |
| 2008 Q3 | -6834.00 USD | 28.21% |
| 2008 Q2 | -9520.00 USD | 46.61% |
| 2008 Q1 | -17.83 Thousand USD | -34.78% |
| 2008 Q4 | -1.82 Million USD | -26545.32% |
| 2008 FY | - USD | -7375.61% |
| 2007 FY | - USD | -1448.06% |
| 2007 Q4 | -13.22 Thousand USD | -882.84% |
| 2007 Q2 | -13 Thousand USD | -303.1% |
| 2007 Q1 | -3225.00 USD | 0.0% |
| 2007 Q3 | -1346.00 USD | 89.65% |
| 2006 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 48.988% |
| Cerus Corporation | -26.53 Million USD | 74.073% |
| OrthoPediatrics Corp. | -8.38 Million USD | 17.909% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 34.442% |
| Talis Biomedical Corporation | -66.04 Million USD | 89.583% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 58.74% |
| Inogen, Inc. | -45.67 Million USD | 84.938% |
| Spectral AI, Inc. | -12.26 Million USD | 43.892% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 85.574% |
| CVRx, Inc. | -38.73 Million USD | 82.236% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -95.012% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 43.173% |
| Orthofix Medical Inc. | -86.98 Million USD | 92.091% |
| Venus Concept Inc. | -26.11 Million USD | 73.653% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 86.177% |
| Bioventus Inc. | -23.07 Million USD | 70.178% |
| BrainsWay Ltd. | -2.31 Million USD | -197.708% |
| Envoy Medical, Inc. | -18.23 Million USD | 62.276% |
| electroCore, Inc. | -17.76 Million USD | 61.261% |
| IceCure Medical Ltd | -15.25 Million USD | 54.894% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 86.171% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 59.183% |
| MaxCyte, Inc. | -44.12 Million USD | 84.409% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 41.476% |
| Nexalin Technology, Inc. | -5.69 Million USD | -20.871% |
| PAVmed Inc | -75.74 Million USD | 90.917% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 87.202% |
| RxSight, Inc. | -41.03 Million USD | 83.235% |
| Sight Sciences, Inc. | -49.41 Million USD | 86.077% |
| SI-BONE, Inc. | -34.44 Million USD | 80.027% |
| TELA Bio, Inc. | -40.63 Million USD | 83.068% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 88.199% |
| Treace Medical Concepts, Inc. | -39 Million USD | 82.363% |
| LivaNova PLC | 39.01 Million USD | 117.634% |
| 908 Devices Inc. | -34.02 Million USD | 79.78% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 93.779% |
| Nemaura Medical Inc. | -7.28 Million USD | 5.586% |
| NeuroPace, Inc. | -22.83 Million USD | 69.869% |
| LENSAR, Inc. | -8.71 Million USD | 21.046% |
| Apyx Medical Corporation | -18.11 Million USD | 62.014% |
| Cutera, Inc. | -136.56 Million USD | 94.962% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -103.551% |
| BioSig Technologies, Inc. | -28.15 Million USD | 75.56% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 373.451% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 67.221% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 101.794% |
| Axonics, Inc. | 7.77 Million USD | 188.489% |
| Outset Medical, Inc. | -153.78 Million USD | 95.526% |
| IRIDEX Corporation | -7.44 Million USD | 7.626% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 92.986% |
| IRadimed Corporation | 20.8 Million USD | 133.076% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 14.661% |
| Telesis Bio, Inc. | -40.49 Million USD | 83.009% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 118.758% |
| Varex Imaging Corporation | 67.2 Million USD | 110.238% |
| Quipt Home Medical Corp. | 44.07 Million USD | 115.611% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 36.706% |
| Pulmonx Corporation | -55.09 Million USD | 87.512% |
| Dynatronics Corporation | -976 Thousand USD | -604.915% |
| Modular Medical, Inc. | -17.1 Million USD | 59.773% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 52.502% |
| Semler Scientific, Inc. | 23.58 Million USD | 129.166% |
| InMode Ltd. | 196.28 Million USD | 103.505% |
| Bruker Corporation | 599 Million USD | 101.149% |
| Cytosorbents Corporation | -28.81 Million USD | 76.12% |
| DexCom, Inc. | 916.7 Million USD | 100.751% |
| Align Technology, Inc. | 799.03 Million USD | 100.861% |
| Viveve Medical, Inc. | -20.61 Million USD | 66.629% |
| ZimVie Inc. | 91.07 Million USD | 107.554% |
| Movano Inc. | -29.12 Million USD | 76.378% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -56.08% |
| Nexalin Technology, Inc. | -5.69 Million USD | -20.871% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -95.012% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 96.466% |
| Profound Medical Corp. | -27.12 Million USD | 74.634% |
| Insulet Corporation | 323.6 Million USD | 102.126% |
| enVVeno Medical Corporation | -25.01 Million USD | 72.5% |
| Surmodics, Inc. | 1.18 Million USD | 679.127% |
| iCAD, Inc. | -6.56 Million USD | -4.799% |
| Nuwellis, Inc. | -16.35 Million USD | 57.936% |
| Biotricity, Inc. | -8.82 Million USD | 22.068% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 92.897% |
| Aethlon Medical, Inc. | -11.84 Million USD | 41.936% |
| InspireMD, Inc. | -20.91 Million USD | 67.099% |
| PAVmed Inc. | -75.74 Million USD | 90.917% |
| BIOLASE, Inc. | -15.13 Million USD | 54.554% |
| Beyond Air, Inc. | -59.03 Million USD | 88.345% |
| FONAR Corporation | 28.25 Million USD | 124.353% |
| AxoGen, Inc. | -13.32 Million USD | 48.379% |
| Vivani Medical, Inc. | -26.6 Million USD | 74.143% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 128.035% |
| Inari Medical, Inc. | 7.11 Million USD | 196.725% |
| UFP Technologies, Inc. | 72.74 Million USD | 109.458% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -103.203% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -11.761% |
| Tenon Medical, Inc. | -15.52 Million USD | 55.693% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 54.932% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 83.412% |
| AdaptHealth Corp. | -171.09 Million USD | 95.979% |
| Sintx Technologies, Inc. | -6.6 Million USD | -4.243% |
| NanoVibronix, Inc. | -3.43 Million USD | -100.292% |
| Quanterix Corporation | -38.08 Million USD | 81.937% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 36.706% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 23033.41% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 97.519% |
| TransMedics Group, Inc. | -7.6 Million USD | 9.509% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 68.39% |
| NeuroMetrix, Inc. | -7.09 Million USD | 3.041% |
| Hyperfine, Inc. | -47.06 Million USD | 85.381% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 88.2% |
| Biomerica, Inc. | -5.99 Million USD | -14.801% |
| Bone Biologics Corporation | 479.57 Thousand USD | 1534.617% |
| AVITA Medical, Inc. | -39.56 Million USD | 82.612% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 24.996% |
| Silk Road Medical, Inc | -45.08 Million USD | 84.738% |